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PERFORMANCE OF THE PSOROPTES OVIS ANTIBODY ELISA IN THE FACE 18 
OF LOW LEVEL MITE INFESTATION 19 
ABSTRACT 20 
Psoroptes ovis mites, the causative agent of sheep scab, can severely compromise sheep 21 
welfare and production.  However, in subclinical infections, mite detection is difficult, 22 
increasing the risk of spread.  A recent serodiagnostic test, based on detecting host antibodies 23 
to the P. ovis allergen, Pso o 2, has made the detection of subclinical infection possible.  The 24 
use of this test was demonstrated in subclinical situations, through an opportunistic 25 
observational study on an extensive hill farm and a lowland flock with recently introduced, 26 
quarantined livestock.  Twelve animals were tested from each group.  Breeding ewes and 27 
lambs on the hill farm had seroprevalences of 16% (12.5 – 17.8%) and 8.3% (4.8 – 10.1%), 28 
respectively.  Quarantined store lambs had a seroprevalence of 16.7% (13.2 – 18.5%); no 29 
evidence of P. ovis was found in quarantined replacement ewes.  By detecting subclinical 30 
infection, this serological test could be a powerful tool in sheep scab control, for quarantine 31 
procedures, accreditation programs and possibly regional or national eradication protocols. 32 
KEYWORDS 33 
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35 
3 
 
 
 
INTRODUCTION 36 
Psoroptes ovis is a non-burrowing parasitic mite of sheep, the causative agent of sheep scab, 37 
which has a significant detrimental effect on the welfare of clinically affected animals.1  It is 38 
estimated to cost the UK sheep industry £8 million per year in lost production and 39 
preventative measures2 largely due to weight loss and lamb mortality.3  The mites spend their 40 
whole lifecycle on the host and the propagation of disease requires the transfer of at least one 41 
viable ovigerous female mite to a new animal.4  This transfer can occur either via direct 42 
contact, or through fomites, such as pieces of wool on fence posts or handling facilities, 43 
where mites can remain viable for up to 16 days.5 6   44 
Individual animals on which mite numbers are low may show mild or inapparent clinical 45 
signs, so that infection can easily go undetected.  This is a high-risk situation for the spread of 46 
infection.  Low mite numbers can occur during the ‘lag’ and ‘decline’ phases of infection,7 47 
when the fleece is short8 and in some breeds without dense fleeces.8   Babcock and Black, 48 
1933,5 found mites could remain hidden on sheep for up to two years.  Traditional diagnostic 49 
methods, using microscopic mite identification have low sensitivity, especially in these 50 
subclinical infestations.9   51 
In response to these diagnostic difficulties and the ongoing, endemic nature of sheep scab in 52 
the UK,10 new immunological methods have been employed to produce an indirect antibody 53 
enzyme linked immunosorbent assay (ELISA) to detect immune responses to P. ovis 54 
infection.11  A recombinant form of the P. ovis allergen, Pso o 2, is used to detect anti-Pso o 2 55 
antibodies in sheep serum and can be used to diagnose sheep scab as early as two weeks post-56 
infestation.12  When trialled in a variety of circumstances, the Pso o 2 ELISA has been shown 57 
to be highly effective in detecting infection,13 with a sensitivity of 93% and specificity of 58 
90%.12 Further optimisation has resulted in an improved assay with a sensitivity of 98.2% and 59 
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a specificity of 96.5% (S. Burgess, unpublished observations).  The test indicates exposure to 60 
infection, but cannot currently discriminate between an active infestation and a recently 61 
resolved infestation, as such animals can remain positive after effective treatment.13  62 
Therefore, it is best employed alongside treatment history and at a group, or flock level, to 63 
assess for the presence or absence of disease in a flock, rather than diagnosis in individual 64 
animals.   65 
The Pso o 2 ELISA has been assessed in a flock outbreak of sheep scab13 but not in a field 66 
situation without obvious clinical disease, where mite numbers may be low.  The purpose of 67 
this report was to demonstrate the performance of the ELISA in circumstances where P. ovis 68 
mite numbers were extremely low. This included the testing of asymptomatic sheep after 69 
purchase by a lowland farm, and testing of animals on an extensive hill farm from which 70 
some of the purchased animals had come.  71 
 72 
MATERIALS AND METHODS 73 
To demonstrate the application of the Pso o 2 ELISA in situations where P. ovis mite 74 
numbers may be low, the test was applied in a quarantine situation on a lowland farm, where 75 
the purchased sheep had no clinical signs of sheep scab, and on an extensive hill farm, where 76 
subclinical infection may have been present.  In early September 2017, 50 Scottish Blackface 77 
store lambs were sold from an extensive hill farm (Farm 1) in the west of Scotland to a 78 
lowland commercial sheep flock situated in the south east of Scotland (Farm 2).  A possibility 79 
of subclinical infection with P. ovis existed owing to the common grazing and unfenced 80 
boundaries on the hill farm.  The consequences of introducing P. ovis to a naïve flock can be 81 
severe.3   82 
5 
 
 
 
The flock on Farm 1 consisted of 900 Scottish Blackface breeding ewes.  Scottish Blackface 83 
sheep are not densely fleeced and can maintain P. ovis mite numbers at low levels without 84 
clinical signs.8  They were grazed at low stocking densities on 1677 hectares of common hill 85 
grazing at 170 to 1025 metres above sea level.  The area of this farm that the purchased store 86 
lambs had come from was separated into two ‘hefts’ (groups of sheep accustomed to grazing 87 
in a certain area of the hill).  Staff on Farm 1 had not observed signs of sheep scab for at least 88 
three years; nevertheless, all breeding sheep were treated with 1ml per 20kg bodyweight of 89 
2% long-acting injectable moxidectin (20mg/ml, Cydectin LA, Zoetis) in October every year 90 
(including 2017) as a precautionary measure.   91 
The flock on Farm 2 was free from clinical signs of sheep scab and consisted of 300 breeding 92 
ewes and ten terminal sire rams.  The sheep were intensively grazed on enclosed, improved 93 
pasture and rough common pasture, unused by other flocks.  Sixty replacement Scottish mule 94 
ewes had also been bought into Farm 2 from another source in early September and placed in 95 
the field next to the store lambs, with only a single wire fence separating them.  Due to a 96 
failure of quarantine procedures the new stock (store lambs and replacement ewes) had had 97 
contact with other sheep on the farm, without the use of precautionary acaricide treatments.  98 
Therefore the risk of the introduction of infection was high and the incoming animals were 99 
screened for sheep scab to provide evidence for the justification of whole flock treatment.   100 
Blood samples were analysed from 12 Scottish Blackface store lambs (originating from Farm 101 
1) and 12 replacement ewes (from other sources) on Farm 2, six weeks after purchase.  The 102 
seropositive lambs from Farm 2 were re-tested, plus a further 12 store lambs from the same 103 
group.  In addition, blood samples were analysed from 25 ewes (a minimum of 12 from each 104 
heft) and 12 lambs from Farm 1, in November 2017.  All blood samples were collected as 105 
whole blood into vacutainers without anticoagulant and allowed to clot, then refrigerated 106 
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until testing was undertaken.  The samples were tested using the Pso o 2 sheep scab ELISA, 107 
using reagents and conditions developed by MRI.12  Testing was undertaken by MRI; except 108 
for the samples from the first 12 store lambs on Farm 2 and repeat samples from the positive 109 
animals in this group, which were carried out by Biobest Laboratories Ltd.   110 
Superficial skin scrapes and clear adhesive tape were used to collect samples from multiple 111 
locations on a mildly pruritic lamb on Farm 1 and the lambs with positive serology samples 112 
on Farm 2.14  These samples were collected from areas of wool with yellow discolouration 113 
and skin with slight hyperkeratosis, found on the neck and flank.  Both ears of the lambs on 114 
Farm 2 were flushed, as previously described.15  These samples were examined 115 
microscopically for identification of ectoparasites.16 116 
The indication to test twelve animals per management group is based on an estimated within 117 
flock prevalence of 20%, providing a minimum test accuracy of 95%, and test sensitivity of 118 
98.2% and specificity of 96.5% at the selected optical density (OD) cut-off (S. Burgess, 119 
unpublished observations).  The test sensitivity and specificity were used to calculate the 120 
minimum (Min) and maximum (Max) potential seroprevalence in each group tested, using the 121 
following formula: 122 
Min = 100 * (P - ((1 - (SP / 100)) * N)) / N 123 
Max = 100 * (P + ((1 - (S / 100)) * N)) / N 124 
Where P is the number of positive test results, S is the test sensitivity, SP is the test 125 
specificity and N is number of animals tested.  The arithmetic mean of the OD was calculated 126 
for each test group by adding together all the OD results for that group and dividing by the 127 
number tested. 128 
RESULTS 129 
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On Farm 1 (Table 1), one of 12 lambs (8.3%) was found to be seropositive, giving a potential 130 
group seroprevalence between 4.8-10.1%.  Four of 25 ewes (16%) were found to be 131 
seropositive, hence the potential group seroprevalence in the ewe flock was estimated to be 132 
between 12.5-17.8%. 133 
Of the Scottish Blackface store lambs that were tested on Farm 2, two of 24 lambs (8.3%) 134 
were found to be seropositive (Table 1) giving a potential group seroprevalence of between 135 
4.8 and 10.1%.  One of these lambs was found to be seropositive when first tested and then 136 
found to be seronegative on re-test.  There was no evidence of exposure to sheep scab in the 137 
replacement ewes (Table 1).  All ELISA results are available in Appendix 1. 138 
No mites were found in any of the superficial skin scrape or ear flush samples.  139 
Table 1: Distribution of animals, from a Scottish hill farm (Farm 1) and bought in sheep on a 
Scottish lowland farm (Farm 2), classified as positive by anti-Pso o 2 ELISA. 
Animals sampled Farm Number 
sampled 
Number of 
positive results 
Mean OD450 
(range) 
Group 
seroprevalence (%) 
Lambs 1 12 1 positive 
1 inconclusive 
0.205 (0.093 – 
0.519) 
8.3 (4.8 – 10.1) 
Breeding ewes 1 25 4 0.355 (0.07 – 
1.97) 
16 (12.5 – 17.8) 
Store lambs (First 
set tested) 
2 12 2 0.337 (0.08 – 
2.04) 
16.7 (13.2 – 18.5) 
Store lambs 
(repeats) 
2 2 1 1.125 (0.22 – 
0.203) 
- 
Store lambs 
(Second set tested) 
2 12 2 inconclusive 0.215 (0.13 – 
0.4) 
- 
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Replacement ewes 2 12 0 0.185 (0.1 – 
0.3) 
0 
Numbers of animals classified as seropositive for sheep scab based on the ELISA results. 
For samples tested at Biobest, OD450nm > 0.4 = suspicion of infestation, OD450nm > 0.5 = 
positive.  For samples tested at MRI, OD450nm > 0.4 = suspicion of infestation, OD450nm > 
0.432 = positive.  Also shown, an estimate of the group seroprevalence and the prevalence 
range, based on test sensitivity (98.2%) and specificity (96.5%). 
 140 
 141 
DISCUSSION 142 
Here we have demonstrated the use of a serological diagnostic assay, using a single recombinant 143 
protein, for the detection of Psoroptes ovis infestation in sheep,12 in a subclinical situation 144 
where traditional diagnostic methods of mite identification failed.  It has also been 145 
demonstrated here that this new test has the potential to be an effective tool in preventing 146 
disease incursion during the introduction of new or returning stock.  As such, the detection of 147 
P. ovis in subclinical situations represents a step forward for the control of sheep scab, with 148 
potential for the detection and removal, by appropriate treatment, of infection in 149 
asymptomatic flocks and the prevention of P. ovis propagation to uninfected farms.   150 
Recently bought-in animals were assessed using the ELISA, the results of which were used to 151 
justify treatment with macrocyclic lactones; for the whole flock on Farm 2 and previously 152 
untreated lambs on Farm 1.  The judicious use of these products is important to maintain their 153 
efficacy against ectoparasites and endoparasites, as well as reduce their environmental 154 
impact.  This is especially pertinent given the recent UK report of Psoroptes ovis mite 155 
resistance to moxidectin.17 156 
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To prevent the excessive use of acaricides, it is important to minimise false positive results in 157 
the detection of P. ovis.  The ELISA used here detects antibody to a single recombinant 158 
protein, Pso o 2, which is highly specific for sheep scab12 compared with a previously 159 
developed crude Psoroptes mite extract based ELISA.9 18 However, due to the longevity of 160 
the circulating IgG response, the test can give false positive results in sheep that have recently 161 
received effective acaricide treatment13 or self-resolved.7  Test results should therefore 162 
always be interpreted in conjunction with treatment history.  Also, biological tests rarely 163 
achieve 100% specificity, so when low numbers of positive results are seen, as in this case, 164 
where one or two out of 12 samples were positive, they should be interpreted with caution, as 165 
they may not represent a current active infection.  Hence repeat samples and additional 166 
testing are recommended in these circumstances, as were undertaken here.   167 
To obtain meaningful results, additional testing needs to be undertaken in a risk-based 168 
manner.  The analysis of risk should incorporate the number of positive results from initial 169 
testing, the degree of positivity of these results and the on-farm situation.  The farm 170 
assessment should include whether animals are displaying clinical signs consistent with P. 171 
ovis infection, movement of animals, use of common grazing, quarantine and biosecurity 172 
measures, proximity of neighbouring flocks and history of sheep scab in those flocks.  If very 173 
few (1 or 2) of the original samples had low positive results, and the on-farm risk was 174 
considered to be low, monitoring without further testing may be appropriate, or additional 175 
testing could be delayed to increase the likelihood of finding positive animals if infection is 176 
present or recent.  Where low numbers of highly positive samples or potential biosecurity 177 
breaches exist, additional testing would be recommended.  Ideally the same positive animals 178 
should be re-tested, alongside additional animals from the same group, making it pertinent to 179 
record animal identity at the time of sampling.  Where testing of the same animals is not 180 
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possible a representative proportion of the group should be re-tested and  further work is 181 
required to determine what proportion this would be. 182 
One of the store lambs from Farm 2 was initially found to be sero-positive but then displayed 183 
a reduction in test OD value upon re-test, becoming sero-negative. As previously stated the 184 
test is unable to distinguish between active and recently resolved infections, however 185 
reductions in serological responses are observed post-treatment/resolution and a significant 186 
decline in test OD value can be detected within 10 days of treatment (S. Burgess, unpublished 187 
observations). As such, this observation may indicate a resolved infection in this individual.  188 
In these subclinical situations, consideration should also be given to the number of animals 189 
sampled, as the recommendation of sampling 12 animals per group of 2000 sheep is based on 190 
an assumed within flock prevalence of 20%.  The seroprevalence on Farm 1 and the store 191 
lambs of Farm 2 was potentially lower than this, between 4.8 and 18.5%, which may have 192 
reduced the likelihood of detecting infection.  However, by testing 12 lambs from a group of 193 
50, or 12 ewes from a heft of 400 to 500, a higher proportion of each group was tested than 194 
the recommendations stipulate, therefore the likelihood of detecting infection may not have 195 
been reduced overall.  Further work will be required to determine how many animals should 196 
be tested in situations with low seroprevalence.  However, there is a need to balance the 197 
accuracy of testing with the cost to individual farms.  Also, quarantine treatment, rather than 198 
testing, cannot be justified on the basis of cost alone, but an argument should be made for 199 
encouraging the judicious use of acaricides.  200 
Prophylactic use of acaricides is standard practice on farms with common grazing in the UK, 201 
including the one described here, there is a ten-fold increase in the risk of sheep scab 202 
incursion on these farms compared with farms without common grazing.19  Conversely, a low 203 
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seroprevalence of sheep scab was found on the extensive hill farm (Farm 1), compared with a 204 
seroprevalence of 78% found during a clinical outbreak on a lowland farm13 this may reflect 205 
specific management characteristics of extensive hill flocks with common grazing.  On 206 
extensive farms the spread of infection is prevented by low stocking densities.20  Farm 1 had 207 
an average stocking density of approximately one breeding ewe to five acres.  The breed of 208 
sheep farmed8 and flock immunity, can also suppress clinical signs and mite numbers.21  209 
Flock immunity builds as a result of repeated exposure, possibly from untreated sheep that 210 
remain on the hill after a gather20 or co-grazing with other flocks.19   211 
Given the endemic nature of sheep scab in the UK10 the low mite numbers in extensive and 212 
subclinical situations and the poor sensitivity of traditional mite identification methods9 the 213 
use of this new serological test with high specificity for P. ovis12 is necessary to improve 214 
control.  Formal ways to use the test could potentially include accreditation schemes, which 215 
would allow flocks to provide evidence of freedom from P. ovis infection.  Work would need 216 
to be done to establish whether purchasers would seek P. ovis-free flocks for replacements, 217 
and so encourage participation in such a scheme.  Regional or national eradication strategies 218 
may also be considered, as was attempted in one Swiss region, where a crude P. cuniculi 219 
antigen antibody ELISA was used to target treatments.18 220 
The study described here is helpful as an example of how the sheep scab ELISA performs in 221 
a subclinical situation and can be used as part of a quarantine protocol.  We have shown that 222 
it is a powerful tool for flock level surveillance of sheep scab, to target the use of whole flock 223 
treatments and reduce the risks associated with introduced animals.   224 
225 
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ABBREVIATIONS 226 
ELISA – enzyme linked immunosorbent assay 227 
OD – optical density 228 
MRI – Moredun Research Institute  229 
ETHICAL APPROVAL  230 
The work was undertaken as a clinical investigation using validated and commercialised 231 
diagnostics, therefore ethics approval was not sought. 232 
ACKNOWLEDGEMENTS 233 
Rebecca Mearns for advice and support with the diagnostic testing.  The farm staff on Farms 234 
1 and 2 for their willing involvement in this study. 235 
AUTHOR CONTRIBUTIONS 236 
KH collected and analysed the data and drafted the manuscript 237 
SB advised on study design, performed the testing and critiqued the manuscript 238 
VB assisted with data analysis and interpretation, and contributed significantly to manuscript 239 
revision and intellectual content 240 
NS was responsible for study conception and design, data interpretation, manuscript revision 241 
and intellectual content 242 
All authors read and approved the final manuscript 243 
FUNDING 244 
Stewart Burgess is funded by the Scottish Government, Rural and Environment Science and 245 
Analytical Services (RESAS). Neil Sargison is funded by Biotechnology and Biological 246 
Sciences Research Council (BBSRC).  Work undertaken by Kim Hamer was as part of a 247 
Royal (Dick) School of Veterinary Studies Senior Clinical Training Scholarship.  Valentina 248 
13 
 
 
 
Busin was employed by the University of Glasgow School of Veterinary Medicine during her 249 
contribution. 250 
COMPETING INTERESTS 251 
The authors declare that they have no competing interests 252 
 253 
254 
14 
 
 
 
REFERENCES 255 
1. Kirkwood AC. History, biology and control of sheep scab. Parasitol Today. 256 
1986;2:302–7.  257 
2. Nieuwhof GJ, Bishop SC. Costs of the major endemic diseases of sheep in Great 258 
Britain and the potential benefits of reduction in disease impact. Anim Sci. 259 
2005;81:23–9.  260 
3. Sargison N, Scott P, Penny C, Pirie R. The effect of an outbreak of sheep scab 261 
(Psoroptes ovis infestation) during mid-pregnancy on ewe body condition and lamb 262 
birth weights. Vet Rec. 1995;136:287–9.  263 
4. van den Broek AH, Huntley JF. Sheep Scab: the Disease, Pathogenesis and Control. J 264 
Comp Pathol. 2003;128:79–91.  265 
5. Babcock OG, Black WL. The common sheep-scab mite and its control. Texas Agric 266 
Exp Stn Bull. 1933;479:1–34.  267 
6. O’Brien DJ, Gray JS, O’Reilly PF. Survival and retention of infectivity of the mite 268 
Psoroptes ovis off the host. Vet Res Commun. 1994;18:27–36.  269 
7. Bates P. The pathogenesis and ageing of sheep scab lesions - part 1. State Vet J 270 
(United Kingdom). 1997;7:11–5.  271 
8. Bates P. The pathogenesis and ageing of sheep scab lesions - part 2. State Vet J 272 
(United Kingdom). 1997;7:13–6.  273 
9. Ochs H, Lonneux J-F, Losson B., Deplazes P. Diagnosis of psoroptic sheep scab with 274 
an improved enzyme-linked immunosorbent assay. Vet Parasitol. 2001;96:233–42.  275 
10. Bisdorff B, Wall R, Milnes A. Prevalence and regional distribution of scab, lice and 276 
15 
 
 
 
blowfly strike in Great Britain. Vet Rec. 2006;158:749–52.  277 
11. Lee A, Machell J, Van Den Broek A, et al. Identification of an antigen from the sheep 278 
scab mite, Psoroptes ovis, homologous with house dust mite group I allergens. 279 
Parasite Immunol. 2002;24:413–22.  280 
12. Nunn FG, Burgess STG, Innocent G, Nisbet AJ, Bates P, Huntley JF. Development of 281 
a serodiagnostic test for sheep scab using recombinant protein Pso o 2. Mol Cell 282 
Probes. 2011;25:212–8.  283 
13. Burgess ST, Innocent G, Nunn F, et al. The use of a Psoroptes ovis serodiagnostic test 284 
for the analysis of a natural outbreak of sheep scab. Parasit Vectors. 2012;5:7-17.  285 
14. Sargison ND. Differential diagnosis and treatment of sheep scab. In Pract. 1995;17:3–286 
9.  287 
15. Crilly JP, Nunn F, Busin V, et al. Investigation and treatment of ovine psoroptic 288 
otoacariasis. Vet Dermatol. 2016;27:206-252.  289 
16. Ministry of Agriculture, Fish & Food. Manual of veterinary parasitological laboratory 290 
techniques. H.M. Stationery Office, 1986 291 
17. Doherty E, Burgess S, Mitchell S, Wall R. First evidence of resistance to macrocyclic 292 
lactones in Psoroptes ovis sheep scab mites in the UK. Vet Rec. 2018;182:106.  293 
18. Jacober P, Ochs H, Torgerson PR, Schnyder M, Deplazes P. A method for sheep scab 294 
control by applying selective treatment based on flock serology. Vet Parasitol. 295 
2006;136:373–8.  296 
19. Rose H, Wall R. Endemic sheep scab: Risk factors and the behaviour of upland sheep 297 
flocks. Prev Vet Med. 2012;104:101–6.  298 
16 
 
 
 
20. Spence T. Control of sheep scab in Britain. Aust Vet J. 1951;27:136–46.  299 
21. van den Broek AHM, Huntley JF, Machell J, et al. Cutaneous and systemic responses 300 
during primary and challenge infestations of sheep with the sheep scab mite, 301 
Psoroptes ovis. Parasite Immunol. 2000;22:407–14. 302 
303 
 304 
